Your browser doesn't support javascript.
loading
Ureteroscopy during pregnancy: Outcomes and lessons learned over 4 decades at a tertiary center in Norway.
Juliebø-Jones, Patrick; Beisland, Christian; Gjengstø, Peder; Baug, Stephen; Ulvik, Øyvind.
Afiliación
  • Juliebø-Jones P; Department of Urology, Haukeland University Hospital, Bergen, Norway.
  • Beisland C; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Gjengstø P; Department of Urology, Haukeland University Hospital, Bergen, Norway.
  • Baug S; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Ulvik Ø; Department of Urology, Haukeland University Hospital, Bergen, Norway.
Curr Urol ; 17(1): 7-12, 2023 Mar.
Article en En | MEDLINE | ID: mdl-37692136
ABSTRACT

Background:

The management of suspected kidney stone disease in pregnancy is challenging. In cases of persistent flank pain and where investigations may have rendered equivocal results, ureteroscopy (URS) is a recognized diagnostic and therapeutic intervention. This study aimed to investigate the safety and outcomes associated with performing URS during pregnancy, as the technique has evolved over the past 4 decades at our center. Materials and

Methods:

We performed a retrospective analysis of pregnant patients who underwent URS at our tertiary center between 1984 and 2022. Outcomes of interest included anesthetic approach, operative time, hospital stay, and complications.

Results:

Eighty-seven pregnant patients underwent 96 URS procedures, and 60% (n = 57) of these procedures were performed during the third trimester. Overall, 58% (n = 56) of the procedures were achieved with local anesthesia and light sedation. During the most recent decade, the latter was successfully carried out in 97% of the procedures, with the remainder occurring under spinal anesthesia as per patient choice. Overall, 57% (n = 50) of the whole study group had ureteral calculi found at the time of surgery and in 88% (n = 44) of these cases, fragmentation/extraction was performed. The remainder had insertion of ureteral stent with definitive clearance deferred until postpartum. Mean operative time and postprocedure hospital stay was 33 minutes (range, 7-100 minutes) and 2.2 days (range, 0-16 days), respectively. The overall intraoperative and postoperative complication rates were 2% and 11%, respectively. During the final decade, the latter improved to 6% and all adverse events were minor (Clavien I/II), with the exception of a single case. Regarding exit strategy, ureteral stent was placed in 42% (n = 40) of the procedures, 23% (n = 22) had ureteral catheter inserted, and the remainder (35%, n = 34) had none.

Conclusions:

Ureteroscopy can be safely performed during pregnancy using anesthetic approach with local anesthesia and light sedation. Development of a local protocol and multidisciplinary management algorithm are instrumental in enabling the delivery of such a service.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Curr Urol Año: 2023 Tipo del documento: Article País de afiliación: Noruega

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Curr Urol Año: 2023 Tipo del documento: Article País de afiliación: Noruega